Gland Pharma Ltd.

Research Gland Pharma Ltd. (GLAND.NS) on Bullrun: market cap INR 502.19B, P/E 44.4, dividend yield 0.7%. Explore financials, valuation history, model signals, and stock context.

Key Metrics

Valuation Snapshot

latest market cap is INR 502.19B; P/E is 44.4; dividend yield is 0.7%.

Peer valuation comparison

Latest P/E is 44.45x versus a Healthcare sector median of 21.74x (104.4% above).

Latest dividend yield is 0.66% versus a Healthcare sector median of 2.4% (72.5% below).

Valuation history

YearSnapshot dateMarket capP/EDividend yieldAnnual dividend/share
20262026-10-18INR 502.19B44.40.7%20

Dividend history

Latest trailing dividend snapshot: annual dividend/share 20 INR, yield 0.7%.

About Gland Pharma Ltd.

Gland Pharma Limited engages in manufacturing and sale of injectable formulations in India, the United States, Europe, Canada, Australia, New Zealand, and internationally. It engages in research and development of active pharmaceutical ingredient products, including synthesis of complex drug molecules, such as low molecular weight heparins, corticosteroids, peptides, and cytotoxic molecules.

Related stock research

India stocks India Healthcare stocks A-Z stock index

Other Healthcare stocks

Abbott India Ltd. (ABBOTINDIA.NS) Ajanta Pharmaceuticals Ltd. (AJANTPHARM.NS) Alkem Laboratories Ltd. (ALKEM.NS) Aurobindo Pharma Ltd. (AUROPHARMA.NS) Caplin Point Laboratories Ltd. (CAPLIPOINT.NS) Cipla Ltd. (CIPLA.NS) Cohance Lifesciences Ltd. (COHANCE.NS) Divi's Laboratories Ltd. (DIVISLAB.NS) Dr. Reddy's Laboratories Ltd. (DRREDDY.NS) Emcure Pharmaceuticals Ltd. (EMCURE.NS) Glenmark Pharmaceuticals Ltd. (GLENMARK.NS) Granules India Ltd. (GRANULES.NS)

Frequently asked questions

What is Gland Pharma Ltd.'s market cap?

Gland Pharma Ltd.'s market capitalization is INR 502.19B.

What is Gland Pharma Ltd.'s P/E ratio?

Gland Pharma Ltd.'s price-to-earnings (P/E) ratio is 44.4.

Does Gland Pharma Ltd. pay a dividend?

Gland Pharma Ltd. has a dividend yield of 0.7%.

What does Gland Pharma Ltd. do?

Gland Pharma Limited engages in manufacturing and sale of injectable formulations in India, the United States, Europe, Canada, Australia, New Zealand, and internationally. It engages in research and development of active pharmaceutical ingredient products, including synthesis of complex drug molecules, such as low molecular weight heparins, corticosteroids, peptides, and cytotoxic molecules.